Interestingly, in high metastatic breast cancer cells, overexpression of microRNA-103/107 targeted and degraded NF-κB-interacting LncRNA, NKILA, which can interact with NF-κB/IκB to prevent overactivation of NF-κB pathway [68]. Here, NKILA is linked to breast cancer.